P3I
ARKG icon

Progeny 3 Inc’s ARK Genomic Revolution ETF ARKG Stock Holding History

Progeny 3 Inc’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-27,560
Closed -$921K – 23
2018
Q3 		$921K Buy
27,560
+24,330
+753% +$770K 0.64% 18
2018
Q2 		$94K Buy
+3,230
New +$89.9K 0.06% 25

Other funds holding ARKG

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACM
Arlington Capital Management Arlington Heights, Illinois $177M AUM 44.15% 1-Year Est. Return
CFA
Carroll Financial Associates Charlotte, North Carolina $1.88B AUM 20.52% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Financial Engines Advisors
Financial Engines Advisors Santa Clara, California $49.2B AUM 14.31% 1-Year Est. Return
SI
Stephens Inc Little Rock, Arkansas $7.99B AUM 21.6% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
MIAN
Mariner Independent Advisor Network Overland Park, Kansas $2.33B AUM 14.85% 1-Year Est. Return
SCA
Snowden Capital Advisors New York $3.76B AUM 23.4% 1-Year Est. Return

Progeny 3 Inc's ARKG Position: Q4 2018 in Review

Progeny 3 Inc sold out of ARK Genomic Revolution ETF (ARKG) in Q4 2018, closing a stake of 27,560 shares — an estimated $921K sold.

Progeny 3 Inc first reported a position in ARKG in Q2 2018 and held it in 2 quarters. The position peaked at $921K in Q3 2018. 58 funds tracked by Wall St. Rank hold ARKG as of Q4 2018.

  • Progeny 3 Inc reported no remaining ARK Genomic Revolution ETF position as of Q4 2018 after selling out during the quarter.
  • Progeny 3 Inc sold 27,560 ARK Genomic Revolution ETF shares in Q4 2018, an estimated $921K.
  • Progeny 3 Inc first reported a position in ARK Genomic Revolution ETF in Q2 2018 and held it in 2 quarters.
  • Progeny 3 Inc's ARK Genomic Revolution ETF position peaked at $921K in Q3 2018.
  • 58 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q4 2018.

Based on Progeny 3 Inc's 13F filing for Q4 2018, filed 14 Feb 2019.